{"title":"妊娠期肺结核筛查","authors":"G. H. Bothamley","doi":"10.1586/EOG.12.35","DOIUrl":null,"url":null,"abstract":"TB is still a global problem, with a prevalence of 12 million in 2010. The WHO recommends screening for TB in pregnancy. In areas of high TB incidence, isoniazid should be given as preventive therapy in pregnant women with HIV infection who do not have active TB. This review examines the evidence for this recommendation, reviews advances in diagnostic tests for TB infection and how WHO recommendations might be adapted to countries with low and moderate TB incidence. Preventive treatment for TB is shown to be safe in those taking antiretroviral therapy or with concomitant hepatitis.","PeriodicalId":12242,"journal":{"name":"Expert Review of Obstetrics & Gynecology","volume":"25 1","pages":"387-395"},"PeriodicalIF":0.0000,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Screening for tuberculosis in pregnancy\",\"authors\":\"G. H. Bothamley\",\"doi\":\"10.1586/EOG.12.35\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"TB is still a global problem, with a prevalence of 12 million in 2010. The WHO recommends screening for TB in pregnancy. In areas of high TB incidence, isoniazid should be given as preventive therapy in pregnant women with HIV infection who do not have active TB. This review examines the evidence for this recommendation, reviews advances in diagnostic tests for TB infection and how WHO recommendations might be adapted to countries with low and moderate TB incidence. Preventive treatment for TB is shown to be safe in those taking antiretroviral therapy or with concomitant hepatitis.\",\"PeriodicalId\":12242,\"journal\":{\"name\":\"Expert Review of Obstetrics & Gynecology\",\"volume\":\"25 1\",\"pages\":\"387-395\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Review of Obstetrics & Gynecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1586/EOG.12.35\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Obstetrics & Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1586/EOG.12.35","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
TB is still a global problem, with a prevalence of 12 million in 2010. The WHO recommends screening for TB in pregnancy. In areas of high TB incidence, isoniazid should be given as preventive therapy in pregnant women with HIV infection who do not have active TB. This review examines the evidence for this recommendation, reviews advances in diagnostic tests for TB infection and how WHO recommendations might be adapted to countries with low and moderate TB incidence. Preventive treatment for TB is shown to be safe in those taking antiretroviral therapy or with concomitant hepatitis.